Trisalus Life SciencesTLSI
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 27 institutions reported holding Trisalus Life Sciences Inc. (TLSI) in their 13F filings, up 2 from Q1 2024. 6 opened new positions and 4 sold out. The largest holders were Duquesne Family Office ($2.4M), Vanguard Group Inc. ($2.3M) and Highbridge Capital Management LLC ($1.2M). 2 famous investors held it, including Stanley Druckenmiller (0.1% of Duquesne Family Office's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Trisalus Life Sciences Inc.
- CUSIP
- 89680M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $2.2M |
| Exits | 4 | $492K |
All 13F filers, Q1 2024 → Q2 2024: 991,597 shares bought and 132,496 shares sold, net +859,101 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Duquesne Family Office | 0.08% | Add +35.1% | 426,921 | $2.4M |
| Vanguard Group Inc. | 0.00% | Add +148.9% | 416,138 | $2.3M |
| Highbridge Capital Management LLC | 0.31% | New | 214,545 | $1.2M |
| Geode Capital Management, LLC | 0.00% | Add +2.8% | 137,885 | $761K |
| Millennium Management | 0.00% | Add +594.5% | 122,904 | $678K |
| Exos Asset Management LLC | 0.32% | New | 167,610 | $273K |
| Lido Advisors, LLC | 0.00% | New | 44,407 | $245K |
| Wolverine Asset Management LLC | 0.02% | New | 43,480 | $240K |
| HRT Financial LP | 0.00% | New | 35,541 | $196K |
| Connecticut Wealth Management, LLC | 0.01% | Reduce -26.3% | 32,879 | $181K |
| BlackRock Inc. | 0.00% | Reduce -28.2% | 30,270 | $167K |
| Northern Trust Corp. | 0.00% | Reduce -7.9% | 26,176 | $144K |
| Anson Capital, Inc. | 0.13% | No change | 24,415 | $135K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -57.7% | 23,045 | $127K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 15,554 | $86K |
| State Street Corp. | 0.00% | New | 11,100 | $61K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +283.9% | 5,920 | $33K |
| UBS Group AG | 0.00% | Add +408.4% | 1,988 | $11K |
| Morgan Stanley | 0.00% | Reduce -85.2% | 1,972 | $11K |
| Wells Fargo & Company | 0.00% | Reduce -7.0% | 1,226 | $7K |
| Hoertkorn Richard Charles | 0.00% | No change | 668 | $4K |
| GPS Wealth Strategies Group, LLC | 0.00% | Reduce -64.5% | 233 | $1K |
| Bank of America Corp. | 0.00% | Reduce -95.4% | 100 | $552 |
| Signaturefd, LLC | 0.00% | No change | 100 | $552 |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.8% | 20 | $110 |
| Deerfield Management Company, L.P. | 0.00% | No change | 1 | $6 |
| Clear Street LLC | 0.00% | No change | 1 | $6 |
"% of holder's portfolio" is TLSI's weight in each manager's 13F, not the share of Trisalus Life Sciences Inc. the manager owns.